rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
5
|
pubmed:dateCreated |
2009-4-30
|
pubmed:abstractText |
Gene expression reprogramming governs cellular processes such as proliferation, differentiation and cell migration through the complex and tightly regulated control of transcriptional cofactors that exist in multiprotein complexes. Here we describe SCAI (suppressor of cancer cell invasion), a novel and highly conserved protein that regulates invasive cell migration through three-dimensional matrices. SCAI acts on the RhoA-Dia1 signal transduction pathway and localizes in the nucleus, where it binds and inhibits the myocardin-related transcription factor MAL by forming a ternary complex with serum response factor (SRF). Genome-wide expression analysis surprisingly reveals that one of the strongest upregulated genes after suppression of SCAI is beta1-integrin. Decreased levels of SCAI are tightly correlated with increased invasive cell migration, and SCAI is downregulated in several human tumours. Functional analysis of the beta1-integrin gene strongly argues that SCAI is a novel transcriptional cofactor that controls gene expression downstream of Dia1 to dictate changes in cell invasive behaviour.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, CD29,
http://linkedlifedata.com/resource/pubmed/chemical/DNA-Binding Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/MKL1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/MKL1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Oncogene Proteins, Fusion,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Small Interfering,
http://linkedlifedata.com/resource/pubmed/chemical/Serum Response Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Trans-Activators,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factors
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1476-4679
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
557-68
|
pubmed:meshHeading |
pubmed-meshheading:19350017-Amino Acid Sequence,
pubmed-meshheading:19350017-Animal Structures,
pubmed-meshheading:19350017-Animals,
pubmed-meshheading:19350017-Antigens, CD29,
pubmed-meshheading:19350017-Binding Sites,
pubmed-meshheading:19350017-Cell Line,
pubmed-meshheading:19350017-Cell Line, Tumor,
pubmed-meshheading:19350017-Cell Movement,
pubmed-meshheading:19350017-Cell Nucleus,
pubmed-meshheading:19350017-DNA-Binding Proteins,
pubmed-meshheading:19350017-Down-Regulation,
pubmed-meshheading:19350017-Enhancer Elements, Genetic,
pubmed-meshheading:19350017-Gene Expression,
pubmed-meshheading:19350017-Gene Expression Regulation, Neoplastic,
pubmed-meshheading:19350017-Humans,
pubmed-meshheading:19350017-Mice,
pubmed-meshheading:19350017-Molecular Sequence Data,
pubmed-meshheading:19350017-Neoplasm Invasiveness,
pubmed-meshheading:19350017-Oncogene Proteins, Fusion,
pubmed-meshheading:19350017-Protein Binding,
pubmed-meshheading:19350017-RNA, Small Interfering,
pubmed-meshheading:19350017-Sequence Homology, Amino Acid,
pubmed-meshheading:19350017-Serum Response Factor,
pubmed-meshheading:19350017-Trans-Activators,
pubmed-meshheading:19350017-Transcription Factors
|
pubmed:year |
2009
|
pubmed:articleTitle |
SCAI acts as a suppressor of cancer cell invasion through the transcriptional control of beta1-integrin.
|
pubmed:affiliation |
Institute of Pharmacology, University of Heidelberg, Im Neuenheimer Feld 366, Heidelberg 69120, Germany.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|